Patient


  • Ira Spector SFA Therapeutics
    Image attribution tooltip
    Permission granted by Ira Spector SFA Therapeutics
    Profile

    A biotech CEO’s favorite ‘F’ word

    At SFA Therapeutics, patients are the “focus” of Ira Spector’s approach to changing the course of autoimmune disease.

    By Jan. 26, 2023
  • Johanna Mercier headshot
    Image attribution tooltip
    Permission granted by Gilead Sciences
    Q&A

    Gilead’s commercial chief on why 2023 will be a ‘coming out’ year

    With a rapidly expanding oncology pipeline and a new approval in HIV, Johanna Mercier discusses Gilead’s quest to transform.

    By Jan. 26, 2023
  • Lauren Lazar Calcium
    Image attribution tooltip
    Permission granted by Lauren Lazar Calcium
    Podcast

    Woman of the Week: Dr. Lauren Lazar

    As Calcium’s medical director, Lazar is leveraging next-generation innovation to create strategic connections between science and marketing for healthcare brands.

    By Jan. 25, 2023
  • Viewed from above, a rendering of the COVID-19 virus sits in the center of a clay, red basketball court.
    Image attribution tooltip
    Enes Evren via Getty Images
    Profile

    Pro sports’ COVID protocols led to real-world data impacts for pharma

    After years of pioneering new methods for using data and technology to improve patient health outcomes, IQVIA’s Christina Mack is on the cusp of a research revolution.

    By Jan. 16, 2023
  • financial storm
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    How biotechs can weather the market storm

    Execs at JPM sound off on moves companies can make to survive the challenging market conditions.

    By Jan. 13, 2023
  • pink hourglass
    Image attribution tooltip
    Stock via Getty Images
    Profile

    A new mission in menopause — extending the lives of women

    Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives.

    By Jan. 5, 2023
  • spilled vial
    Image attribution tooltip
    Stock via Getty Images

    Nonprofits are bridging R&D’s valley of death

    How charitable firms such as Advancium are helping to right the market wrongs of drug development.

    By Kelly Bilodeau • Jan. 4, 2023
  • crystal ball 2023
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

    A preview of the top trends on the minds of industry and market leaders for the new year.

    By Jan. 3, 2023
  • A person in a white lab coat holds an Ipad and pen and sits across from someone gesturing with their hands.
    Image attribution tooltip
    iStock via Getty Images
    Q&A

    To drive trial diversity, one company is bringing them to the patient

    For Lightship, increasing patient access to clinical trials is about meeting them where they are — literally.

    By Dec. 21, 2022
  • Signs in florida for a monkeypox vaccine site
    Image attribution tooltip
    Joe Raedle via Getty Images

    With mpox cases mysteriously dwindling, scientists search for answers

    Was it a public health victory? Or did mpox ‘burn itself out?’ An epidemiologist weighs in.

    By Kelly Bilodeau • Dec. 19, 2022
  • Vicki Goodwin Exelexis
    Image attribution tooltip
    Permission granted by Exelexis’ Dr. Vicki Goodman
    Podcast

    Woman of the Week: Exelixis’ Dr. Vicki Goodman

    With several blockbuster products under her belt, veteran oncologist and drug developer Dr. Vicki Goodman is looking to further evolve Exelixis’ pipeline to address hard-to-treat cancers.

    By Dec. 14, 2022
  • Microscope blood slide
    Image attribution tooltip
    Motortion via Getty Images

    At the heart of hematology breakthroughs, a community of researchers and patients comes together

    As new and advanced therapies are revealed at the annual meeting of the American Society of Hematology this week, the patients are always at the center.

    By Dec. 13, 2022
  • An illustration of two fingers holding a crystal glass pill with a DNA strip floating inside.
    Image attribution tooltip

    Illustration: Alberto Miranda for Industry Dive

    Tracker

    The 2023 PharmaVoice Year in Preview

    Here’s a look at how industry leaders are navigating the key issues of 2023.

    Dec. 12, 2022
  • global health equity
    Image attribution tooltip
    Stock via Getty Images

    The pharma giants making the biggest strides with global drug access

    A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.

    By Kelly Bilodeau • Dec. 12, 2022
  • Charlotte Owens, vice president, head of the Center for Health Equity and Patient Affairs, Takeda
    Image attribution tooltip
    Permission granted by Takeda
    Q&A

    Takeda’s global quest for health equity

    Takeda’s Center for Health Equity and Patient Affairs is built to address health inequality around the world and aims to raise the bar for the pharma industry.

    By Dec. 8, 2022
  • Overhead view of a person holding two white pills in their left hand and a glass of water in their right hand.
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Non-toxic and addiction free: The promise of a new pain med

    Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic.

    By Dec. 1, 2022
  • pills
    Image attribution tooltip
    Stock via Getty Images

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By Nov. 30, 2022
  • Nicole Lambert WoW picture
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Myriad Genetics’ Nicole Lambert

    Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.

    By Nov. 23, 2022
  • Professional headshot of Sana Alajmovic.
    Image attribution tooltip

    Permission granted by Sana Alajmovic

    Profile

    A ‘bold vision’ to prevent diabetes

    Despite hearing that there’s “no money in prevention,” the CEO of Sigrid Therapeutics is forging ahead with the company’s goal of stopping Type 2 diabetes before it starts. 

    By Alexandra Pecci • Nov. 15, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By Nov. 11, 2022
  • IV infusion
    Image attribution tooltip
    Amornrat Phuchom via Getty Images

    While CAR-T wait times remain ‘heartbreaking,’ researchers push for innovations that could help

    Facing an unprecedented manufacturing bottleneck, a new coalition is aiming to create the next generation of CAR-T therapies.

    By Nov. 8, 2022
  • Disabilities
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    The other ‘D’ in DE&I

    How companies can work to include people with disabilities into broader equity aims.

    By Nov. 4, 2022
  • Gulden Mesera wow pix
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: City of Hope’s Gulden Mesara

    Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.

    By Nov. 2, 2022
  • diagram of man, doctor, phone, tablet
    Image attribution tooltip
    Retrieved from Google image.

    While DCTs get all the hype, some industry insiders say the future is a digital hybrid

    Leaders at Veeva believe the wording around decentralized trials has been exaggerated, and that a bigger-picture outlook is important as the pandemic winds down.

    By Nov. 1, 2022
  • A researcher with blue gloves holds a pipette tool in the right hand and a test tube in the left hand.
    Image attribution tooltip
    iStock via Getty Images

    Tips for tackling trial recruitment and retention woes in oncology

    How new tools are helping companies find and keep cancer patients in clinical studies.

    By Kelly Bilodeau • Oct. 31, 2022